Correlation Between InnovAge Holding and CryoCell International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both InnovAge Holding and CryoCell International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InnovAge Holding and CryoCell International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InnovAge Holding Corp and CryoCell International, you can compare the effects of market volatilities on InnovAge Holding and CryoCell International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InnovAge Holding with a short position of CryoCell International. Check out your portfolio center. Please also check ongoing floating volatility patterns of InnovAge Holding and CryoCell International.

Diversification Opportunities for InnovAge Holding and CryoCell International

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between InnovAge and CryoCell is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding InnovAge Holding Corp and CryoCell International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CryoCell International and InnovAge Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InnovAge Holding Corp are associated (or correlated) with CryoCell International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CryoCell International has no effect on the direction of InnovAge Holding i.e., InnovAge Holding and CryoCell International go up and down completely randomly.

Pair Corralation between InnovAge Holding and CryoCell International

Given the investment horizon of 90 days InnovAge Holding Corp is expected to under-perform the CryoCell International. But the stock apears to be less risky and, when comparing its historical volatility, InnovAge Holding Corp is 1.35 times less risky than CryoCell International. The stock trades about -0.27 of its potential returns per unit of risk. The CryoCell International is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  713.00  in CryoCell International on September 1, 2024 and sell it today you would earn a total of  196.00  from holding CryoCell International or generate 27.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

InnovAge Holding Corp  vs.  CryoCell International

 Performance 
       Timeline  
InnovAge Holding Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days InnovAge Holding Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
CryoCell International 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CryoCell International are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, CryoCell International disclosed solid returns over the last few months and may actually be approaching a breakup point.

InnovAge Holding and CryoCell International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with InnovAge Holding and CryoCell International

The main advantage of trading using opposite InnovAge Holding and CryoCell International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InnovAge Holding position performs unexpectedly, CryoCell International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CryoCell International will offset losses from the drop in CryoCell International's long position.
The idea behind InnovAge Holding Corp and CryoCell International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance